Thomas A. Raffin
Director · Akoya Biosciences, Inc.
Individual
- 2024
- Jul 8, 2025
- 2
Other insiders active in the same sector
No other insider has filed at Thomas A. Raffin's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Robert W. Duggan - $51.95M in SMMT purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $51.68M in ELVN purchases and sales in the last 12 months
- Daniel Patrick O'Day - $51.19M in GILD purchases and sales in the last 12 months
- HRTG GPE, LLC - $50.00M in KARD purchases and sales in the last 12 months
- Redmile Group, LLC - $49.64M in ADCT purchases and sales in the last 12 months
- Gary S. Guthart - $48.79M in ISRG purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas A. Raffin?
Thomas A. Raffin is a corporate insider, tracked as Director of Akoya Biosciences, Inc. (AKYA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Thomas A. Raffin last file a Form 4?
The most recent primary Form 4 on record is dated 8 July 2025, one of 2 filings going back to 2024.
